| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |